Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 316 AL 330

Striatal-enriched protein tyrosine phosphatase in Alzheimer's disease

Xu J, Kurup P, Nairn AC, Lombroso PJ.

Adv Pharmacol. 2012;64:303-25. doi: 10.1016/B978-0-12-394816-8.00009-X.

The calcium-sensing receptor: a novel Alzheimer's disease crucial target?

Armato U, Bonafini C, Chakravarthy B, Pacchiana R, Chiarini A, Whitfield JF, Dal Prà I.

J Neurol Sci. 2012 Nov 15;322(1-2):137-40. doi: 10.1016/j.jns.2012.07.031. Epub 2012 Jul 28.

Microvascular burden and Alzheimer-type lesions across the age spectrum

Costanza A, Xekardaki A, Kövari E, Gold G, Bouras C, Giannakopoulos P.

J Alzheimers Dis. 2012;32(3):643-52. doi: 10.3233/JAD-2012-120835.

Effective diagnosis of Alzheimer's disease by means of large margin-based methodology

Chaves R, Ramírez J, Górriz JM, Illán IA, Gómez-Río M, Carnero C; Alzheimer’s Disease Neuroimaging Initiative.

BMC Med Inform Decis Mak. 2012 Jul 31;12:79. doi: 10.1186/1472-6947-12-79.

Oral health of the elderly with Alzheimer's disease

Ribeiro GR, Costa JL, Ambrosano GM, Garcia RC.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Sep;114(3):338-43. doi: 10.1016/j.oooo.2012.03.028.

Tamibarotene: a candidate retinoid drug for Alzheimer's disease

Fukasawa H, Nakagomi M, Yamagata N, Katsuki H, Kawahara K, Kitaoka K, Miki T, Shudo K.

Biol Pharm Bull. 2012;35(8):1206-12. doi: 10.1248/bpb.b12-00314.

TOMM40 association with Alzheimer disease: tales of APOE and linkage disequilibrium

Guerreiro RJ, Hardy J.

Arch Neurol. 2012 Oct;69(10):1243-4. doi: 10.1001/archneurol.2012.1935.

Fibrinogen and altered hemostasis in Alzheimer's disease

Cortes-Canteli M, Zamolodchikov D, Ahn HJ, Strickland S, Norris EH.

J Alzheimers Dis. 2012;32(3):599-608. doi: 10.3233/JAD-2012-120820.

Vascular cognitive impairment and Alzheimer's disease: role of cerebral hypoperfusion and oxidative stress

Kim HA, Miller AA, Drummond GR, Thrift AG, Arumugam TV, Phan TG, Srikanth VK, Sobey CG.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Oct;385(10):953-9. doi: 10.1007/s00210-012-0790-7. Epub 2012 Aug 8.

Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer's disease with normal control comparison

Chang YT, Chang CC, Lin HS, Huang CW, Chang WN, Lui CC, Lee CC, Lin YT, Chen CH, Chen NC.

Acta Neurol Taiwan. 2012 Jun;21(2):64-73.

An update on type 2 diabetes, vascular dementia and Alzheimer's disease

Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ.

Exp Gerontol. 2012 Nov;47(11):858-64. doi: 10.1016/j.exger.2012.07.014. Epub 2012 Aug 3.

Validation of a multiplex assay for simultaneous quantification of amyloid-β peptide species in human plasma with utility for measurements in studies of Alzheimer's disease therapeutics

Lachno DR, Emerson JK, Vanderstichele H, Gonzales C, Martényi F, Konrad RJ, Talbot JA, Lowe SL, Oefinger PE, Dean RA.

J Alzheimers Dis. 2012;32(4):905-18. doi: 10.3233/JAD-2012-121075.

Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease

Giuffrida ML, Tomasello F, Caraci F, Chiechio S, Nicoletti F, Copani A.

Mol Neurobiol. 2012 Dec;46(3):605-13. doi: 10.1007/s12035-012-8313-6. Epub 2012 Aug 12.

The role of natural killer cells in Alzheimer's disease

Jadidi-Niaragh F, Shegarfi H, Naddafi F, Mirshafiey A.

Scand J Immunol. 2012 Nov;76(5):451-6. doi: 10.1111/j.1365-3083.2012.02769.x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias